Lady Comp is 99.3% accurate.
Lady-Comp has a clinically tested Pearl-Index of 0.7. Which means it is 99.3% accurate.
The computers have been clinically tested several times by Prof. Dr. G. Freundl, former Head Physician of the Department of Obstetrics and Gynecology at the Municipal Hospital of Düsseldorf-Benrath, and the results have been presented at various medical conferences in Europe.
Clinical trial "Effectiveness study"
Trial of contraceptive effectiveness of Lady-Comp® ; test of 131 women and 2.843 cycles over 12 month. Field study in Poland. Results: User Pearl-Index 0.64. Under direction of Prof. Ewa Markwitz, 2010
686 women from Germany, Switzerland and Mexico participated in the most recent study for over two years. The study was conducted at the University Hospital in Düsseldorf and resulted in a Pearl Index of 0.7. Please contact us to receive a summary of the study.
Clinical trial "Planning"
Under "Downloads" you will find a summary of the study conducted by Prof. S. Dessole and presented during the "International Meeting on Infertility and Assisted Reproductive Technology" in Porto Cervo in 1997.
The World Health Organization, in the document entitled "Criteria for eligibility for the adoption and continued use of contraceptive methods" (3rd edition 2005), shows statistics for the effectiveness of contraceptive methods in the first year:
Last modifyed: 06. 10. 2011 Filesize: 66.77 kB
"The high measurement accuracy of the temperature sensors and the precise algorithm of the temperature calculation provide a high degree in method safety, which clearly stands out from competitive devices.
The handling and operation of the device is user friendly and easy - all relevant items which ensure a safe and correct application of the device are described comprehensibly in the instructions manual.
Several scientific investigations, which were published in recognized journals, provide substantial evidence of the contraceptive effectiveness and safety of the VE electronic fertility devices. All investigations and studies were conducted independently; none of the participating physicians received any financial grant nor had a relationship with the manufacturer, Valley Electronics, thus allowing the public to consider the independently published data to be reliable and objective."
ClevaMed Dr. med. Andreas Marx